Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Investor Deadline Approaching: Faruqi & Faruqi LLP Investigates Claims on Behalf of Investors of NeuMe

New York, NY - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating claims on behalf of investors who purchased NeuMe (OTC: NEUM) securities.

The investigation centers around potential securities law violations by NeuMe, including the possibility of false or misleading statements made to investors. On February 24, 2023, NeuMe announced that it would be ceasing all operations and winding down its business.

Faruqi & Faruqi, LLP is seeking investors who purchased NeuMe securities between [insert time frame] and [insert time frame] to contact the firm to discuss the possibility of recovering their investment losses.

Investors who purchased NeuMe securities and suffered losses are encouraged to contact Faruqi & Faruqi, LLP to learn more about the investigation and potential legal remedies. The deadline to file a motion to consolidate the cases is [insert deadline].

Faruqi & Faruqi, LLP is a nationally recognized law firm with a strong track record of success in securities cases. The firm has a team of experienced attorneys who have successfully represented investors in cases against publicly traded companies.

Contact: Faruqi & Faruqi, LLP info@faruqilaw.com (212) 983-9331 (877) 247-6487 (toll-free)

About Faruqi & Faruqi, LLP: Faruqi & Faruqi, LLP is a leading national securities law firm with offices in New York, California, and Maryland. Since 1995, the firm has represented investors and employees in securities-related class actions, derivative actions, and individual cases. The firm's attorneys have achieved significant results for clients and have received numerous awards and recognition for their work.